Buy Urecholine
Urecholine

1.36
Urecholine (bethanechol) is a cholinergic agent used to treat non-obstructive urinary retention. It assists bladder function by stimulating the muscles to contract, facilitating easier urination. This medication is commonly used post-operatively or in other clinical settings where the bladder requires support to empty effectively.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | EMS trackable (5-9 days)
Product is shipped in a fully discreet envelope with no content disclosure, including all required documentation inside

Product Sheet

Active Ingredient(s)
Bethanechol
Reference Brand
Myotonine
Product Form
Tablet
Regulatory Classification
Rx
Primary Category
Bladder & Urinary, Urinary Retention
Product Category
Urologicals, Parasympathomimetics
Pharmacological Class
Choline ester
Manufacturer Description
Used to treat the inability to empty the bladder naturally, particularly after surgery or childbirth.
Mechanism of Action
It stimulates the nerves of the bladder, causing the bladder muscle to contract and the outlet to relax, which allows the patient to pass urine.
Route of Administration
Oral
Onset Time
30-90 minutes
Duration
6 hours
Contraindications
Asthma, Hyperthyroidism, Peptic ulcer, Urinary tract obstruction
Severe Adverse Events
Severe drop in blood pressure, Bronchospasm, Seizures
Common Side Effects
Sweating, Flushing, Salivation
Uncommon Side Effects
Abdominal cramps, Nausea, Frequent urge to urinate
Drug Interactions
Quinidine, Procainamide, Ganglionic blockers
Pregnancy Safety Warnings
Avoid unless essential
Age Restrictions
Children only under specialist supervision
Storage Guidelines
Store at room temperature
Related Products
Distigmine

Urecholine FAQ

Can I travel with Urecholine and still pass airport security?

Yes, Urecholine tablets can be carried in your hand luggage. Keep them in the original prescription label or packaging, and present the prescription or a doctor’s note if requested by security personnel.

Does Urecholine interact with over-the-counter herbal supplements?

Some herbal products, such as ginkgo biloba or St. John’s wort, can affect liver enzymes and potentially alter bethanechol levels. Inform your pharmacist or prescriber about any supplements you are taking.

What does the tablet imprint look like?

A typical 25 mg Urecholine tablet bears the imprint “U-25” on one side. Imprint details may vary by manufacturer; always verify the appearance against the pharmacy label.

Is Urecholine detectable in drug-testing for pilots or athletes?

Bethanechol is not a controlled substance and does not appear on standard occupational or sports drug-testing panels. However, disclose all medications to the relevant authority to avoid misunderstandings.

How does Urecholine differ from other bladder-stimulating agents?

Unlike anticholinergic drugs that relax bladder muscle, Urecholine actively stimulates detrusor contraction. This opposite mechanism makes it suitable for urinary retention, whereas anticholinergics are used for overactive bladder.

What were the key clinical trials that led to Urecholine’s approval?

Early randomized trials in the 1970s demonstrated that bethanechol improved post-operative bladder emptying compared with placebo, establishing its efficacy for urinary retention. Detailed trial data are available in historic pharmacology journals.

Can I store Urecholine in a bathroom cabinet?

It is best to store the tablets in a cool, dry place away from humidity and temperature fluctuations. A bathroom cabinet may be humid; therefore, keep the medication in a bedroom drawer or kitchen cupboard instead.

Why does the price of Urecholine vary between pharmacies?

Pricing differences arise from manufacturer discounts, NHS dispensing fees, and local pharmacy procurement contracts. Generic equivalents containing bethanechol may be less expensive but should be prescribed by a clinician familiar with the patient’s needs.

Is there a risk of dependence on Urecholine?

Bethanechol does not produce psychoactive effects and is not associated with physical dependence. However, long-term use should be regularly reviewed to ensure continued clinical benefit.

What is Urecholine?

Urecholine is a brand-name medication that contains bethanechol as its sole active ingredient. It belongs to the bladder and urinary therapeutic class and is formulated as a 25 mg oral pill. In the United Kingdom, Urecholine is a prescription-only (POM) medicine regulated by the Medicines and Healthcare products Regulatory Agency (MHRA). The drug is used to stimulate smooth-muscle activity in the urinary tract, helping patients who have difficulty emptying their bladder after surgery or due to certain neurological conditions.

How Urecholine Works in the Body

Bethanechol is a muscarinic cholinergic agonist. It mimics the action of the neurotransmitter acetylcholine at muscarinic receptors, especially the M₃ subtype found in the bladder detrusor muscle and gastrointestinal tract. By binding to these receptors, bethanechol:

  • Increases intracellular calcium in smooth-muscle cells
  • Enhances contraction of the detrusor muscle, promoting bladder emptying
  • Improves gastrointestinal motility, although its primary clinical use is for urinary indications

The drug is absorbed well after oral ingestion, reaching peak plasma concentrations within 30-60 minutes. Its effects typically begin within an hour, with a duration of action of about 2-4 hours, which is why dosing is usually divided throughout the day.

Conditions Treated by Urecholine

Urecholine is licensed in the UK for the treatment of:

  • Post-operative urinary retention - inability to void following abdominal or pelvic surgery.
  • Neurogenic urinary retention - bladder emptying problems caused by spinal cord injury or multiple sclerosis, when other treatments are unsuitable.

These indications are supported by the product’s summary of characteristics (SmPC) and are reflected in NHS prescribing guidance.

Evidence-Based Off-Label Uses

Some clinicians prescribe bethanechol off-label for post-operative ileus (delayed intestinal motility after surgery). Small observational studies have suggested a modest benefit, but large-scale randomised trials are lacking. Consequently, the use for ileus is not approved by the MHRA and should only be considered under specialist supervision.

Disclaimer: Off-label use requires medical supervision and an individualized risk-benefit assessment.

Who Should (Not) Use Urecholine?

Absolute Contra-indications

  • Known hypersensitivity to bethanechol or any excipients in the tablet
  • Mechanical obstruction of the urinary tract (e.g., bladder stones, severe prostatic hypertrophy)
  • Mechanical obstruction of the gastrointestinal tract (e.g., intestinal blockage)
  • Severe asthma or chronic obstructive pulmonary disease with bronchospasm
  • Recent myocardial infarction or uncontrolled cardiac arrhythmias

Relative Contra-indications

  • Renal impairment (dose may need adjustment)
  • Hepatic impairment (monitor for increased cholinergic effects)
  • Pregnancy (Category B in the UK; use only if benefit outweighs risk)
  • Breast-feeding (excreted in milk; caution advised)

Special Populations

  • Elderly patients may be more sensitive to cholinergic side effects; start at the lowest effective dose.
  • Pediatric use is not established for Urecholine; it is generally not prescribed to children.

Safety Profile: Side Effects and Interactions

Common Side Effects

  • Abdominal cramps - usually transient, may improve with dose reduction.
  • Diarrhoea - mild to moderate; maintain adequate hydration.
  • Flushing or warmth - related to vasodilation.
  • Increased urinary frequency - expected therapeutic effect, but may be inconvenient.

Serious Adverse Events

  • Bronchospasm - can be life-threatening in asthmatic patients.
  • Severe hypotension - due to excessive vasodilation; requires immediate medical attention.
  • Bradycardia - may occur with high plasma concentrations.

If any of these serious symptoms develop, seek urgent medical care.

Drug Interactions

  • Anticholinergic agents (e.g., atropine, antihistamines) - may diminish bethanechol’s efficacy.
  • Beta-blockers - additive bradycardic effect; monitor heart rate.
  • Cholinesterase inhibitors (e.g., donepezil) - may increase cholinergic activity, raising the risk of side effects.

Patients should provide a full medication list, including over-the-counter drugs and herbal supplements, to their prescriber.

Food and Lifestyle Interactions

  • Food: Take Urecholine with a glass of water; food does not significantly affect absorption but may reduce gastrointestinal upset if taken with meals.
  • Alcohol: Moderate consumption is permissible, but excessive alcohol may exacerbate hypotension.
  • Driving: Generally safe, but if dizziness or excessive sweating occurs, avoid operating machinery.

How to Take Urecholine

  • Standard dosing: 25 mg taken orally three times daily (approximately every 8 hours). The tablets should be swallowed whole with water.
  • Dose adjustments:
  • In patients with renal or hepatic impairment, the prescriber may lower the dose or extend the dosing interval.
  • For elderly patients, the initial dose may be reduced to 25 mg once daily, titrating upward as tolerated.
  • Missed dose: Take the missed dose as soon as remembered unless it is near the time of the next scheduled dose; do not double the dose.
  • Overdose: Symptoms may include severe sweating, vomiting, diarrhoea, hypotension, and bradycardia. Call 999 or contact a local emergency department immediately; treatment is supportive, with atropine available as an antidote for severe cholinergic toxicity.
  • Discontinuation: Abrupt cessation is usually safe, but if the drug has been used for an extended period, a gradual taper may be recommended to avoid rebound urinary retention.

Monitoring and Follow-Up

  • Clinical assessment: Evaluate bladder emptying efficiency (post-void residual volume) after the first few doses.
  • Blood pressure and heart rate: Check regularly, especially in patients with cardiovascular disease.
  • Renal and hepatic function: Baseline labs are advisable before initiating therapy; repeat if dose adjustments are considered.

Regular follow-up with a GP or urologist ensures optimal therapeutic effect while minimising adverse events.

Storage and Handling

  • Store tablets at room temperature (15-25 °C), protected from light and moisture.
  • Keep the medication in its original blister pack until use.
  • Do not use after the expiry date printed on the packaging.
  • Dispose of unused tablets via a pharmacy take-back scheme or as directed by local waste-disposal regulations.

Medication-Specific Glossary

Muscarinic Agonist
A compound that activates muscarinic acetylcholine receptors, leading to increased smooth-muscle contraction.
Detrusor Muscle
The smooth-muscle layer of the bladder wall responsible for expelling urine during voiding.
Parasympathetic Nervous System
The branch of the autonomic nervous system that promotes “rest-and-digest” activities, including bladder contraction.
Bioavailability
The proportion of an orally administered drug that reaches systemic circulation unchanged; bethanechol has high oral bioavailability.

Medical Disclaimer

This article provides educational information about Urecholine and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.

Information for Urecholine is sourced from established medical standards and updated frequently. It is provided for general guidance and should be confirmed with a healthcare professional before use.
Categories
Hoe kunt u Haar & Huidverzorging kopen - Retin-A crème kopen Treatment guide for Fat Loss Treatment Hong Kong: - Buy Clenbuterol Hong Kong